期刊的影响因子--文章列表

期刊文章列表
Kyung Bo Kim（Department of Pharmaceutics）.Proteasomal adaptations to FDA-approved proteasome inhibitors:a potential mechanism for drug resistance?[J].癌症耐药(英文),2021,第3期 Haiyun Zhang，Alexander Steed，Milo Co，Xiaozhuo Chen（Department of Biological Science；Edison Biotechnology Institute；Interdisciplinary Graduate Program in Molecular and Cellular Biology；Heritage College of Osteopathic Medicine；Department of Biomedical Sciences）.Cancer stem cells,epithelial-mesenchymal transition,ATP and their roles in drug resistance in cancer[J].癌症耐药(英文),2021,第3期 Xin Yu，Xiangling Chu，Yan Wu，Juan Zhou，Jing Zhao，Fei Zhou，Chaonan Han，Chunxia Su（Department of Oncology）.Favorable clinical outcomes of checkpoint inhibitorbased combinations after progression with immunotherapy in advanced non-small cell lung cancer[J].癌症耐药(英文),2021,第3期 I.V.Bijnsdorp，Godefridus J.Peters（Department of Medical Oncology；Department of Urology；Department of Biochemistry）.Protective autophagy by thymidine causes resistance to rapamycin in colorectal cancer cells in vitro[J].癌症耐药(英文),2021,第3期 Natasha Rinne，Elizabeth LChristie，Anastasia Ardasheva，Chun Hei Kwok，Nikita Demchenko，Caroline Low，Catherine Tralau-Stewart，Christina Fotopoulou，Paula Cunnea（Department of Surgery&Cancer；Peter MacCallum Cancer Centre；Department of Metabolism Digestion&Reproduction；Takeda Academic Innovation）.Targeting the PI3K/AKT/mTOR pathway in epithelial ovarian cancer,therapeutic treatment options for platinum-resistant ovarian cancer[J].癌症耐药(英文),2021,第3期 Jacopo Giuliani，Andrea Bonetti（Department of Oncology）.Cost-effectiveness of Osimertinib in activating epidermal growth factor receptor gene(EGFR)-mutations in first-line for advanced non-small cell lung cancer[J].癌症耐药(英文),2021,第3期 Alice Romagnoli，Cristina Maracci，Mattia D’Agostino，Anna La Teana，Daniele Di Marino（Department of Life and Environmental Sciences；New York-Marche Structural Biology Center（NY-MaSBiC））.Targeting mTOR and eIF4E:a feasible scenario in ovarian cancer therapy[J].癌症耐药(英文),2021,第3期 Jordan M.Hotz，Joanna R.Thomas，Emily N.Katz，Robert W.Robey，Sachi Horibata，Michael M.Gottesman（Laboratory of Cell Biology；Zebrafish Core）.ATP-binding cassette transporters at the zebrafish blood-brain barrier and the potential utility of the zebrafish as an in vivo model[J].癌症耐药(英文),2021,第3期 Iwao Ojima（Institute of Chemical Biology and Drug Discovery）.Recent advances in tumor-targeting chemotherapy drugs[J].癌症耐药(英文),2021,第3期 Elisabetta Pietri，Rita Balsano，Matilde Coriano，Fabio Gelsomino，Francesco Leonardi，Simona Bui，Letizia Gnetti，Raffaele Dalla Valle，Ingrid Garajová（Medical Oncology Unit；Department of Oncology and Hematology；Unit of Pathological Anatomy；Department of Medicine and Surgery）.The implication of liquid biopsies to predict chemoresistance in pancreatic cancer[J].癌症耐药(英文),2021,第3期 Jean-Marie Michot，Alice Buet-Elfassy，Maxime Annereau，Julien Lazarovici，Alina Danu，Clémentine Sarkozy，Claude Chahine，Camille Bigenwald，Jacques Bosq，Julien Rossignol，Patricia Romano-Martin，Capucine Baldini，David Ghez，Peggy Dartigues，Christophe Massard，Vincent Ribrag（Gustave Roussy；Gustave Roussy；Gustave Roussy；Gustave Roussy）.Clinical significance of the loss of CD20 antigen on tumor cells in patients with relapsed or refractory follicular lymphoma[J].癌症耐药(英文),2021,第3期 Roberto Gutierrez，Timothy R.O’Connor（Department of Cancer Biology；Irell&Manella Graduate School of Biological Sciences；Department of Cancer Biology）.DNA direct reversal repair and alkylating agent drug resistance[J].癌症耐药(英文),2021,第2期 Yang Meng，Lei Qiu，Su Zhang，Junhong Han（Research Laboratory of Cancer Epigenetics and Genomics）.The emerging roles of E3 ubiquitin ligases in ovarian cancer chemoresistance[J].癌症耐药(英文),2021,第2期 Alberto Gabizon，Patricia Ohana，Yasmine Amitay，Jenny Gorin，Dina Tzemach，Lidia Mak，Hilary Shmeeda（Nano-oncology Research Center；Hebrew University-School of Medicine；Lipomedix Pharmaceuticals Ltd.）.Liposome co-encapsulation of anti-cancer agents for pharmacological optimization of nanomedicine-based combination chemotherapy[J].癌症耐药(英文),2021,第2期 Amber SMoody，Paul ADayton，William C.Zamboni（UNC Eshelman School of Pharmacy；UNC Lineberger Comprehensive Cancer Center；Carolina Institute for Nanomedicine；Joint Department of Biomedical Engineering）.Imaging methods to evaluate tumor microenvironment factors affecting nanoparticle drug delivery and antitumor response[J].癌症耐药(英文),2021,第2期 Wing-Kee Lee，Frank Thévenod（Institute for Physiology）.Teaching an old dog new tricks:reactivated developmental signaling pathways regulate ABCB1 and chemoresistance in cancer[J].癌症耐药(英文),2021,第2期 Jac A.Nickoloff，Lynn Taylor，Neelam Sharma，Takamitsu A.Kato（Department of Environmental and Radiological Health Sciences）.Exploiting DNA repair pathways for tumor sensitization,mitigation of resistance,and normal tissue protection in radiotherapy[J].癌症耐药(英文),2021,第2期 Franco Muggia，Andrea Bonetti（Department of Medical Oncology）.History of intraperitoneal platinum drug delivery for ovarian cancer and its future applications[J].癌症耐药(英文),2021,第2期 Richard Callaghan，Mary Board（Human Disease and Membrane Transport Laboratory；St.Hilda's College）.UCP2-Taking the heat out of P-glycoprotein?[J].癌症耐药(英文),2021,第2期 Joanna Kopecka，Chiara Riganti（Department of Oncology）.Overcoming drug resistance in glioblastoma:new options in sight?[J].癌症耐药(英文),2021,第2期 Aleksandra Benko，David Medina-Cruz，Ada Vernet-Crua，Catherine P.O'Connell，MałgorzataŚwiętek，Hamed Barabadi，Muthupandian Saravanan，Thomas J.Webster（AGH University of Science and Technology；Department of Chemical Engineering；Institute of Macromolecular Chemistry；Department of Pharmaceutical Biotechnology；Department of Medical Microbiology and Immunology）.Nanocarrier drug resistant tumor interactions:novel approaches to fight drug resistance in cancer[J].癌症耐药(英文),2021,第2期 Siraj Shaikh，Javed Shaikh，Yusufi Sadia Naba，Kailas Doke，Khursheed Ahmed，Mujahid Yusufi（Post-Graduate Department of Chemistry and Research Center；Advanced Scientific Research Laboratory）.Curcumin:reclaiming the lost ground against cancer resistance[J].癌症耐药(英文),2021,第2期 Norman Fultang，Madhuparna Chakraborty，Bela Peethambaran（Department of Pathology and Laboratory Medicine；Department of Biological Sciences）.Regulation of cancer stem cells in triple negative breast cancer[J].癌症耐药(英文),2021,第2期 Kathryn F.Tonissen，Sally-Ann Poulsen（Griffith Institute for Drug Discovery；School of Environment and Science）.Carbonic anhydrase XII inhibition overcomes P-glycoprotein-mediated drug resistance:a potential new combination therapy in cancer[J].癌症耐药(英文),2021,第2期 Wanqi Wang，Noor A Lokman，Tannith M Noye，Anne M Macpherson，Martin K Oehler，Carmela Ricciardelli（Adelaide Medical School；Department of Gynaecological Oncology）.ABCA1 is associated with the development of acquired chemotherapy resistance and predicts poor ovarian cancer outcome[J].癌症耐药(英文),2021,第2期 Tara Hyder，Juan Luis Gomez Marti，Azadeh Nasrazadani，Adam M.Brufsky（University of Pittsburgh Physicians；Department of Pathology；UPMC Hillman Cancer Center）.Statins and endocrine resistance in breast cancer[J].癌症耐药(英文),2021,第2期 Zally Torres-Martinez，Yamixa Delgado，Yancy Ferrer-Acosta，Ivette J Suarez-Arroyo，Freisa M.Joaquin-Ovalle，Louis J.Delinois，Kai Griebenow（Chemistry Department；Biochemistry&Pharmacology Department；Neuroscience Department；Biochemistry Department）.Key genes and drug delivery systems to improve the efficiency of chemotherapy[J].癌症耐药(英文),2021,第1期 Paolo Chetta，Giorgia Zadra（University of Milan；Current Address:Boehringer Ingelheim RCV GmbH&Co.KG；Department of Oncologic Pathology；Current Address:Institute of Molecular Genetics）.Metabolic reprogramming as an emerging mechanism of resistance to endocrine therapies in prostate cancer[J].癌症耐药(英文),2021,第1期 Daeun Shim，Lei Duan，Carl G.Maki（Department of Cell and Molecular Medicine）.P53-regulated autophagy and its impact on drug resistance and cell fate[J].癌症耐药(英文),2021,第1期 Robert Clarke，Brandon C.Jones，Catherine M.Sevigny，Leena A.Hilakivi-Clarke，Surojeet Sengupta（The Hormel Institute and Department of Biochemistry；Department of Oncology；The Jackson Laboratory）.Experimental models of endocrine responsive breast cancer:strengths, limitations, and use[J].癌症耐药(英文),2021,第1期首页上一页 1 2 3 下一页尾页共有3页，转到页

期刊文章列表